Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: Spain Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20164
20172
20181
20193
20205
20214
20234
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17
Completed6
Active, not recruiting3
Terminated2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Eisai Inc.2
Genmab2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Regeneron Pharmaceuticals2
Ability Pharmaceuticals SL1
Artios Pharma Ltd1
BioNTech SE1
Bolt Biotherapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms30
Ovarian Neoplasms20
Colorectal Neoplasms14
Neoplasms10
Breast Neoplasms9
Uterine Cervical Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Neoplasm Metastasis7
Stomach Neoplasms7
Fallopian Tube Neoplasms6

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.